SB 1722 – Oklahoma

Status: Inactive / Dead
Year Introduced: 2020

An Act relating to prescription drugs; providing for codification; defining terms; requiring drug manufacturer to notify Insurance Department of price increase of certain drug; requiring drug manufacturer to notify Department in writing within certain time period of introduction of new drug in certain circumstances; requiring manufacturer to report certain data in writing to Department within certain time period; requiring pharmacy benefit managers to report certain data to Department within certain time period; applying certain protections to information reported under act; requiring drug distributor to report certain data to Department within certain time period; requiring certain insurers to annually report certain data on prescription drugs; requiring registration of certain entities with Department; requiring entities to pay annual assessment to implement act; specifying costs included in assessment; specifying minimum amount for assessment; providing terms for collection of assessment; requiring reporting entity to certify certain information; providing civil penalty for violation of act; authorizing the Department to audit certain data at Department expense; authorizing Department to require submission of corrective action plan in event of violation; authorizing Department to hold public hearings and subpoena certain entities; requiring Department to develop and publish certain data on website; declaring certain data confidential; authorizing Department to share certain data with Attorney General; and providing an effective date.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found